SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-002288
Filing Date
2021-01-08
Accepted
2021-01-08 09:10:34
Documents
6
Period of Report
2021-01-07
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm212074d1_8k.htm 8-K 25548
2 EXHIBIT 5.1 tm212074d1_ex5-1.htm EX-5.1 6593
3 EXHIBIT 10.1 tm212074d1_ex10-1.htm EX-10.1 214002
4 EXHIBIT 99.1 tm212074d1_ex99-1.htm EX-99.1 9662
5 GRAPHIC tm212074d1_ex5-1img001.jpg GRAPHIC 6854
6 GRAPHIC tm212074d1_ex5-1img002.jpg GRAPHIC 23646
  Complete submission text file 0001104659-21-002288.txt   299454
Mailing Address 375 PHEASANT RUN NEWTOWN PA 18940
Business Address 375 PHEASANT RUN NEWTOWN PA 18940 267-759-3681
Onconova Therapeutics, Inc. (Filer) CIK: 0001130598 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36020 | Film No.: 21515849
SIC: 2834 Pharmaceutical Preparations